HANDOK Inc.

KSE 002390.KS

HANDOK Inc. Operating Income Margin for the year ending December 31, 2023: 2.41%

HANDOK Inc. Operating Income Margin is 2.41% for the year ending December 31, 2023, a -32.79% change year over year. Operating Income Ratio is the proportion of a company's operating income to its net sales, measuring the efficiency of its core business operations in generating profits.
  • HANDOK Inc. Operating Income Margin for the year ending December 31, 2022 was 3.58%, a 5.08% change year over year.
  • HANDOK Inc. Operating Income Margin for the year ending December 31, 2021 was 3.41%, a -64.21% change year over year.
  • HANDOK Inc. Operating Income Margin for the year ending December 31, 2020 was 9.52%, a -21.53% change year over year.
  • HANDOK Inc. Operating Income Margin for the year ending December 31, 2019 was 12.13%, a 246.36% change year over year.
Key data
Date Operating Income Margin EBT Margin Net Income Margin EBITDA Margin
Market news
Loading...
SV Wall Street
KSE: 002390.KS

HANDOK Inc.

CEO Mr. Young-Jin Kim M.B.A.
IPO Date Jan. 4, 2000
Location South Korea
Headquarters 132 Teheran-ro
Employees 938
Sector Healthcare
Industries
Description

Handok Inc. operates as an integrated pharmaceutical company. The company provides ETC and OTC drugs, medical devices, and in-vitro diagnostics instruments and devices. It focuses on various therapeutic areas, such as oncology, diabetes and metabolic disorders, CNS orphan diseases, eye disorders, and other disease areas. The company also offers healthcare products comprising food supplements under the NatureSet and Culturelle brands; food and beverages; and medical nutrition products. Handok Inc. has a strategic collaboration agreement with AUM Biosciences Pte. Ltd. and CMG Pharmaceutical Co. Ltd. for the development, manufacturing, and commercialization of CHC2014, a pan-TRK inhibitor for cancer treatment. The company was formerly known as Handok Pharmaceuticals Co., Ltd and changed its name to Handok Inc. in July 2013. Handok Inc. was founded in 1954 and is based in Seoul, South Korea.

Similar companies

000640.KS

Dong-A Socio Holdings Co., Ltd.

USD 65.38

-0.04%

000100.KS

Yuhan Corporation

USD 83.97

-5.00%

001630.KS

Chong Kun Dang Holdings Corp.

USD 31.05

-1.12%

000020.KS

Dongwha Pharm.Co.,Ltd

USD 4.07

-1.95%

001060.KS

JW Pharmaceutical Corporation

USD 15.49

-2.92%

StockViz Staff

February 4, 2025

Any question? Send us an email